No Data
No Data
Exicure GAAP EPS of -$4.75, Revenue of $0.5M
Exicure | 10-K: FY2024 Annual Report
Express News | Exicure Inc - Cash May Not Be Sufficient to Fund Operations; Doubts Ability to Continue as Going Concern
Express News | Exicure, Inc. Reports Full Year 2024 Financial Results
Express News | Exicure Announces Australian Patent Office Issued Patent Titled 'GPCR Heteromer Inhibitors and Uses Thereof.'
$XCUR Stock Is up 14% Today. Here's What We See in Our Data.